American Society for Clinical Pharmacology and Therapeutics
63 episodes
5 months ago
The ASCPT Podcast Channel is the official podcast stream of the American Society for Clinical Pharmacology & Therapeutics (ASCPT). The goal of the channel is to provide further insight into articles published in the ASCPT’s family of journals.
All content for ASCPT Podcast Channel is the property of American Society for Clinical Pharmacology and Therapeutics and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The ASCPT Podcast Channel is the official podcast stream of the American Society for Clinical Pharmacology & Therapeutics (ASCPT). The goal of the channel is to provide further insight into articles published in the ASCPT’s family of journals.
Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research
ASCPT Podcast Channel
13 minutes 41 seconds
1 year ago
Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research
Clinical Pharmacology & Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled “Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.” Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Rebecca Miksad, and Guest Editor Dr. Sebastian Schneeweiss to discuss the relevance of this theme in today’s clin pharm landscape as well as what types of submissions they’d most like to receive. If you have questions about submitting for this pharmacoepidemiology-themed issue, please contact Deputy Managing Editor Alaina Webster at alaina@ascpt.org.
ASCPT Podcast Channel
The ASCPT Podcast Channel is the official podcast stream of the American Society for Clinical Pharmacology & Therapeutics (ASCPT). The goal of the channel is to provide further insight into articles published in the ASCPT’s family of journals.